212 related articles for article (PubMed ID: 33511221)
1. Clinical Outcomes of Ceftriaxone vs Penicillin G for Complicated Viridans Group Streptococci Bacteremia.
Wo S; Dubrovskaya Y; Siegfried J; Papadopoulos J; Jen SP
Open Forum Infect Dis; 2021 Jan; 8(1):ofaa542. PubMed ID: 33511221
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of Viridians Group of Streptococci isolated from infective endocarditis patients from 2018 to 2023.
Jagadeesan N; Karur K; Nandini MP; Manjunath CN; Prapulla Kumari N; Praveen Kumar HD
Indian J Med Microbiol; 2024; 49():100576. PubMed ID: 38556250
[TBL] [Abstract][Full Text] [Related]
3. The clinical impact of patients with bloodstream infection with different groups of Viridans group streptococci by using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS).
Su TY; Lee MH; Huang CT; Liu TP; Lu JJ
Medicine (Baltimore); 2018 Dec; 97(50):e13607. PubMed ID: 30558035
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
Shelburne SA; Lasky RE; Sahasrabhojane P; Tarrand JT; Rolston KV
Clin Infect Dis; 2014 Jul; 59(2):223-30. PubMed ID: 24755857
[TBL] [Abstract][Full Text] [Related]
5. Viridans group streptococci bloodstream infections in neutropenic adult patients with hematologic malignancy: Single center experience.
Radocha J; Paterová P; Zavřelová A; Víšek B; Gabalec F; Žemličková H; Žák P
Folia Microbiol (Praha); 2018 Mar; 63(2):141-146. PubMed ID: 28776170
[TBL] [Abstract][Full Text] [Related]
6. Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group.
Pfaller MA; Jones RN; Marshall SA; Edmond MB; Wenzel RP
Diagn Microbiol Infect Dis; 1997 Dec; 29(4):259-63. PubMed ID: 9458983
[TBL] [Abstract][Full Text] [Related]
7. Comparative Genomics of Streptococcus oralis Identifies Large Scale Homologous Recombination and a Genetic Variant Associated with Infection.
Joyce LR; Youngblom MA; Cormaty H; Gartstein E; Barber KE; Akins RL; Pepperell CS; Palmer KL
mSphere; 2022 Dec; 7(6):e0050922. PubMed ID: 36321824
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of penicillin and ceftriaxone resistance among children with pneumococcal bacteremia.
Silverstein M; Bachur R; Harper MB
Pediatr Infect Dis J; 1999 Jan; 18(1):35-41. PubMed ID: 9951978
[TBL] [Abstract][Full Text] [Related]
9. Impact of Intermediate Susceptibility to Penicillin on Antimicrobial Treatment and Outcomes of Endocarditis Caused by Viridans and Gallolyticus Group Streptococci.
Escrihuela-Vidal F; Berbel D; Fernández-Hidalgo N; Escolà-Vergé L; Muñoz P; Olmedo M; Goenaga MÁ; Goikoetxea J; Fariñas MC; De Alarcón A; Miró JM; Ojeda G; Plata A; Cuervo G; Carratalà J;
Clin Infect Dis; 2023 Nov; 77(9):1273-1281. PubMed ID: 37345869
[TBL] [Abstract][Full Text] [Related]
10. Endocarditis Caused by Highly Penicillin-Resistant Viridans Group Streptococci: Still Room for Vancomycin-Based Regimens.
Pericàs JM; Nathavitharana R; Garcia-de-la-Mària C; Falces C; Ambrosioni J; Almela M; García-González J; Quintana E; Marco F; Moreno A; Bayer AS; Miró JM; Karchmer AW;
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182540
[TBL] [Abstract][Full Text] [Related]
11. Clinical and microbiological profile of Viridans group streptococcal bacteraemia; experience from South India.
Arjun R; Niyas VKM; Hussain F; Surendran S; Mohan V
Infez Med; 2024; 32(1):37-44. PubMed ID: 38456022
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2004 Jan; 48(1):86-92. PubMed ID: 14693523
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic susceptibility patterns of viridans group streptococci isolates in the United States from 2010 to 2020.
Singh N; Poggensee L; Huang Y; Evans CT; Suda KJ; Bulman ZP
JAC Antimicrob Resist; 2022 Jun; 4(3):dlac049. PubMed ID: 35599725
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of neutropenic hemato-oncological patients with viridans group streptococci (VGS) bloodstream infection based on penicillin susceptibility.
Shargian L; Paul M; Nachshon T; Ayada G; Nesher L; Raanani P; Ben-Zvi H; Henig O; Yahav D
Eur J Clin Microbiol Infect Dis; 2023 Feb; 42(2):177-182. PubMed ID: 36502498
[TBL] [Abstract][Full Text] [Related]
15. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Viridans Group Streptococcal Bacteremia in Neutropenic and Non-neutropenic Patients: A Single Center Case-Case-Control Study.
Dulanto Chiang A; Sinaii N; Palmore TN
Open Forum Infect Dis; 2018 Jan; 5(1):ofx260. PubMed ID: 29955617
[TBL] [Abstract][Full Text] [Related]
17. Prevalence rate and antibiotic susceptibility of oral viridans group streptococci (VGS) in healthy children population.
Rozkiewicz D; Daniluk T; Sciepuk M; Zaremba ML; Cylwik-Rokicka D; Luczaj-Cepowicz E; Milewska R; Marczuk-Kolada G; Stokowska W
Adv Med Sci; 2006; 51 Suppl 1():191-5. PubMed ID: 17460837
[TBL] [Abstract][Full Text] [Related]
18. [Classical and new approaches in laboratory diagnosis of viridans streptococci].
Ergin A
Mikrobiyol Bul; 2010 Jul; 44(3):495-503. PubMed ID: 21064001
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of ceftriaxone use compared to standard of therapy in methicillin susceptible staphylococcal aureus (MSSA) bloodstream infections.
Patel UC; McKissic EL; Kasper D; Lentino JR; Pachucki CT; Lee T; Lopansri BK
Int J Clin Pharm; 2014 Dec; 36(6):1282-9. PubMed ID: 25186790
[TBL] [Abstract][Full Text] [Related]
20. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.
Presterl E; Grisold AJ; Reichmann S; Hirschl AM; Georgopoulos A; Graninger W
J Antimicrob Chemother; 2005 Jan; 55(1):45-50. PubMed ID: 15563519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
